Wednesday, 28 September, 2022
TopicCovid vaccines

Topic: Covid vaccines

11% of 69 crore eligible people have taken Covid precaution dose, says govt, blames waning fear

Slight rise in precaution dose coverage after vaccines were made free but govt officials cite ‘Covid surge in many countries’ to emphasise need to increase uptake.

BA.2.75 — new Covid variant detected in India a mystery, but could ‘have immune-escape property’

This Omicron sub-lineage may have increased ability to infect people who’ve been infected before, or are vaccinated, according to some scientists. However, there's no govt data on this.

DCGI approval in, but here’s why you can’t choose Corbevax as your booster just yet

Corbevax was, over the weekend, approved for heterologous use as a Covid booster shot by apex drug regulator Drugs Controller General of India.

Our take on WHO’s Covid deaths estimate, RBI rate hike, SC’s vaccine take — in 50 words

ThePrint view on the most important issues this week.

2nd Covid shot from Serum Institute, Rs 225/dose: All about Covovax, new jab approved for teens

Covovax, developed by US company Novavax & manufactured in India by Serum Institute, is a protein-based vaccine developed from SARS-CoV-2 strain.

The ZyCoV-D mystery: 3 months after arrival in Bihar, not a single Covid vaccine shot given

Covid vaccine developed by Zydus Lifesciences was approved for use in those aged 12 and above in September 2021. Centre ordered 1 crore doses last year & delivery began in February.

We can’t ‘boost’ our way out of the Covid pandemic for the long term

While the vaccine is effective at preventing severe disease, it is likely that boosters will become an annual shot. Here's the science behind it.

New Covid vaccine developed in Germany produces better immune response in cancer patients

Peptide-based vaccine CoVac-1 has been developed by researchers at University of Tübingen. They say it induces better T-cell immune response in immunocompromised patients.

Now, data proves Covid vaccines work. So trust science, make third dose easily accessible

ThePrint view on the most important issues, instantly.

DCGI gives emergency use approval to Biological E’s Corbevax vaccine for kids aged 12-18

It is the second Covid vaccine to get approval for use in children in India after Bharat Biotech's Covaxin.

On Camera


The logo of the Adani Group is seen on the facade of one of its buildings on the outskirts of Ahmedabad | Reuters file photo

From ports to energy transition — Adani Group to invest over $100 billion in next decade

Speaking at Forbes Global CEO Conference in Singapore, Adani said the group intends to do more as a solar player & has earmarked 70% of the investment for the energy transition space.


Parts of Iranian made 'suicide' drone Shahed-136 after being shot down by the Ukrainian military | Reuters

All about Shahed-136, Iran’s ‘kamikaze’ drone that Russia is using to strike Ukraine

Over the past few days, Russia has hit multiple targets using these Iranian-supplied drones—including civilian structures and amenities—leading to the death of several Ukrainians.
Illustration by Soham Sen | ThePrint

AAP’s filling a big vacuum in Indian politics. Question is how long it can sustain without ideology

If you find admiration for AAP qualified, if not muted among many of the Modi-BJP’s critics, it is because they question it for its lack of ideological clarity. Especially on secularism.